clinical trial · NCT06887972
A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries
Vertex Pharmaceuticals Incorporated·phase4·completed·n = 100
Acute PainSuzetrigine
brief summary
The study evaluates the effectiveness, safety, and tolerability of SUZ as part of multimodal therapy (MMT) in treating acute postoperative pain.
started
Mar 21, 2025
primary completion
Oct 24, 2025
completion
Nov 7, 2025
last updated
Nov 16, 2026
official title
A Phase 4, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Aesthetic or Reconstructive Surgeries
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol